About

Welcome to the Lupus Forum. The Lupus Forum is an educational website developed under the auspices of the University of Leeds and is dedicated to the dissemination of the latest developments in the field of lupus. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of lupus, its treatments, and clinical practice.

Lupus Forum content is free from commercial bias, and feature leading experts sharing their knowledge and experience in the form of video tutorials.

Membership of the Lupus Forum is free to everyone. Register as a member and have unlimited free access to all of the materials contained within the site.

A two-part series exploring the challenges in treating lupus nephritis
Lupus Member's Survey

NEW Monthly literature search podcasts – available now

Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Professor Chris Edwards, Consultant Rheumatologist and Honorary Chair of Clinical Rheumatology University Hospital Southampton, UK. Together, they discuss the latest developments and perspectives in glucocorticoid tapering, TYK2 therapy in rheumatic disease, as well as SLE QoL and LLDAS.

Latest Updates

Publications ▼
All
Publication thumbnail: TYK2: An emerging therapeutic target in rheumatic disease

TYK2: An emerging therapeutic target in rheumatic disease

Publication thumbnail: Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: A multinational observational cohort study

Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: A multinational observational cohort study

Publication thumbnail: Lupus low disease activity state and organ damage in relation to quality of life in systemic lupus erythematosus: A cohort study with up to 11 years of follow-up

Lupus low disease activity state and organ damage in relation to quality of life in systemic lupus erythematosus: A cohort study with up to 11 years of follow-up

Publication thumbnail: Evaluation of RNase Therapy in Systemic Lupus Erythematosus: A Randomised Phase 2a Clinical Trial of RSLV-132

Evaluation of RNase Therapy in Systemic Lupus Erythematosus: A Randomised Phase 2a Clinical Trial of RSLV-132

Steering Committee